T1	Participants 66 85	HIV-infected adults
T2	Participants 176 232	Persons infected with human immunodeficiency virus (HIV)
T3	Participants 590 623	randomizing HIV-positive patients
T4	Participants 1197 1250	Ninety-seven participants were included in the study.
